These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35846871)

  • 1. Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.
    Savage MO; Fernandez-Luque L; Graham S; van Dommelen P; Araujo M; de Arriba A; Koledova E
    Patient Prefer Adherence; 2022; 16():1663-1671. PubMed ID: 35846871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Augmented Reality Mobile App (Easypod AR) as a Complementary Tool in the Nurse-Led Integrated Support of Patients Receiving Recombinant Human Growth Hormone: Usability and Validation Study.
    Baños RM; Peltonen LM; Martin B; Koledova E
    JMIR Nurs; 2023 Apr; 6():e44355. PubMed ID: 37083627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.
    Foo J; Maghnie M; Colao A; Vlachaki I; Colombo G
    Clinicoecon Outcomes Res; 2019; 11():525-537. PubMed ID: 31692496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod
    Mancini A; Vergani E; Bruno C; Palladino A; Brunetti A
    Front Endocrinol (Lausanne); 2019; 10():416. PubMed ID: 31316468
    [No Abstract]   [Full Text] [Related]  

  • 6. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study.
    Rodríguez Arnao MD; Rodríguez Sánchez A; Díez López I; Ramírez Fernández J; Bermúdez de la Vega JA; Yeste Fernández D; Chueca Guindulain M; Corripio Collado R; Pérez Sánchez J; Fernández González A
    Endocr Connect; 2019 Sep; 8(9):1240-1249. PubMed ID: 31484160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR; Roca F; Rubstein A; Chareca C
    Front Med Technol; 2021; 3():609878. PubMed ID: 35047902
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.
    Su PH; Yang C; Chao MC; Chiang CL
    JMIR Pediatr Parent; 2021 Jan; 4(1):e14774. PubMed ID: 33448936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the TUITEK
    Assefi AR; Graham S; Crespo ML; Debicki M; Reston J; Gonzalez J; Jheeta A; Koledova E
    Front Endocrinol (Lausanne); 2023; 14():1129385. PubMed ID: 37091843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence and long-term growth outcomes: results from the easypod
    Koledova E; Stoyanov G; Ovbude L; Davies PSW
    Endocr Connect; 2018 Aug; 7(8):914-923. PubMed ID: 29976785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Health in the Management of Pediatric Growth Hormone Therapy - 10 Years of Developments.
    Koledova E; Le Masne Q; Spataru A; Bagha M; Dixon D
    Stud Health Technol Inform; 2021 May; 281():926-930. PubMed ID: 34042809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents.
    Bozzola M; Colle M; Halldin-Stenlid M; Larroque S; Zignani M;
    BMC Endocr Disord; 2011 Feb; 11():4. PubMed ID: 21294891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.
    Sauer M; Abbotts C
    Patient Prefer Adherence; 2018; 12():27-34. PubMed ID: 29343946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Impact of the TUITEK
    Su PH; Malik S; Jheeta A; Lin YF; Su SH; Koledova E; Graham S
    Front Endocrinol (Lausanne); 2022; 13():897956. PubMed ID: 35600589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital technologies to improve the precision of paediatric growth disorder diagnosis and management.
    Dunkel L; Fernandez-Luque L; Loche S; Savage MO
    Growth Horm IGF Res; 2021 Aug; 59():101408. PubMed ID: 34102547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.
    Spataru A; van Dommelen P; Arnaud L; Le Masne Q; Quarteroni S; Koledova E
    BMC Med Inform Decis Mak; 2022 Jul; 22(1):179. PubMed ID: 35794586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.